Your browser doesn't support javascript.
loading
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
Modjarrad, Kayvon; Giersing, Birgitte; Kaslow, David C; Smith, Peter G; Moorthy, Vasee S.
Affiliation
  • Modjarrad K; Initiative for Vaccine Research, World Health Organization, CH-1211 Geneva 27, Switzerland; U.S Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
  • Giersing B; Initiative for Vaccine Research, World Health Organization, CH-1211 Geneva 27, Switzerland.
  • Kaslow DC; PATH, Seattle, WA 98109, USA.
  • Smith PG; London School of Hygiene and Tropical Medicine, London WC1E7HT, UK.
  • Moorthy VS; Initiative for Vaccine Research, World Health Organization, CH-1211 Geneva 27, Switzerland. Electronic address: moorthyv@who.int.
Vaccine ; 34(2): 190-197, 2016 Jan 04.
Article in En | MEDLINE | ID: mdl-26100926
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Clinical Trials as Topic / Immunization / Guidelines as Topic / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines / Drug Discovery Type of study: Guideline Limits: Humans Language: En Journal: Vaccine Year: 2016 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Clinical Trials as Topic / Immunization / Guidelines as Topic / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines / Drug Discovery Type of study: Guideline Limits: Humans Language: En Journal: Vaccine Year: 2016 Type: Article Affiliation country: United States